Babies born by Caesarean section have a greater risk of developing type-1 diabetes than those who are born via normal deliveries, British research suggests.

Researchers from Queen's University Belfast examined data from 20 published studies on children with type-1 diabetes who were born by caesarean. The results found that that babies born by caesarean had a 20 percent higher risk of diabetes compared with babies born by natural birth. The normal risk of a baby developing type 1 diabetes is three in 1,000

Babies born by Caesarean section have a greater risk of developing type-1 diabetes than those who are born via normal deliveries, UK research suggests.

Researchers from Queen's University Belfast examined data from 20 published studies on children with type-1 diabetes who were born by caesarean. The results found that that babies born by caesarean had a 20 per cent higher risk of diabetes compared with babies born by natural birth. The normal risk of a baby developing type 1 diabetes is three in 1,000

Exposure to arsenic, a toxic chemical often found at low levels in public drinking water, may increase the risk of developing type 2 diabetes, according to researchers.

The findings, published in the Aug. 20 issue of the Journal of the American Medical Association, indicate that people with high levels of arsenic in their urine were almost four times more likely to have diabetes than those with trace levels

The Methodist Hospital of Houston is experimenting with a new approach to diabetic treatment by removing a patient's pancreas and injecting the insulin-producing cells into the patient's limb.

The pilot study, made on its first patient a month ago, seeks to discover methods to prevent the onset of diabetes for persons whose pancreas was removed due to pancreatitis, trauma, cancer or tumors

Harvard University scientists have made a set of new stem cell lines that make it possible for researchers to explore 10 different genetic disorders including muscular dystrophy and juvenile diabetes. Researchers hope the new research will help them find new treatments for genetic diseases.

The cells were taken from skin and bone marrow of diseased patients and re-programmed to behave like cells from days-old embryos. The subjects, whose ages ranged from one month to 57-years-old, suffered from a range of conditions from Down Syndrome to Parkinson's disease